Real-time enrollment status for this advanced unresectable melanoma clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 10:23 AM UTC
| NCT Number | NCT07237100 |
| Recruiting Status | Recruiting |
| Condition | Advanced Unresectable Melanoma |
| Phase | PHASE2 |
| Target Enrollment | 10 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Kevin Kim, MD |
| Last Updated on CT.gov | November 19, 2025 (Nov 19, 2025) |
As of July 20, 2026: Clinical trial NCT07237100 is currently recruiting participants. This phase2 study for advanced unresectable melanoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Kevin Kim, MD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07237100 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07237100 was last updated Nov 19, 2025 (November 19, 2025). HelloStudys verifies this status automatically.